To understand the true impact of AI in production processes we can refer to industry leaders like J&J, AstraZeneca, GSK as an example, investing heavily in AI for drug discovery, clinical trial optimization, and regulatory processes.
Another showcase of AI’s growing role in streamlining regulatory submissions and approvals by ensuring compliance with evolving guidelines. These companies are not just using technology to work faster, they are already rethinking the entire drug development process.
In Fedegari we explored the many possibilities offered by AI and embraced its potential by integrating it into key aspects of our daily operations. One of the most impactful applications has been in reviewing User Requirement Specifications (URSs). AI is used to pinpoint compliance issues and identify necessary deviations based on our extensive track record in the field.
This approach not only boosts our performance and accuracy but also significantly reduces response times for URS compliance.
Letting AI do the reviewing work, enables our SMEs to dedicate their valuable time to supporting customers, offering faster, proactive guidance and improving contract management efficiency.